Risky Business? CMS Refining Medicare Rx Risk Adjustment Formula
Executive Summary
The Medicare Rx risk-adjustment formula is likely to include a factor to increase payments for plans that enroll a larger percentage of low-income beneficiaries in the new outpatient drug benefit, Centers for Medicare & Medicaid Services Administrator Mark McClellan said during a Dec. 20 "open door" forum
You may also be interested in...
Part B Average Sales Price Drug Rates Finalized; Zoladex Down 12%
AstraZeneca's prostate cancer therapy Zoladex will be reimbursed at 12% below CMS' previously estimated rate when payment changes for Medicare Part B-covered drugs take effect Jan. 1
Medicare Rx Sponsors Must Notify CMS Of Part D Intentions In February
Potential Medicare Rx plan sponsors will need to tell the Centers for Medicare & Medicaid Services how they intend to participate in the Part D benefit by early February
Medicare Rx Risk Adjustment To Be Based On FEHBP Data Through 2009
The Centers for Medicare & Medicaid Services expects prescription drug risk adjustments for Medicare Part D plans to be based on Blue Shield Federal Employees Health Benefits Program data until the end of 2009